Highlights
- Untreated maternal depression is associated with higher outpatient opioid use (MMEs) through six weeks post-cesarean delivery.
- Inpatient opioid consumption did not differ significantly regardless of depression status, likely due to standardized hospital protocols.
- Both treated and untreated depression correlate with higher perceived pain interference in daily activities at one week postpartum.
- Comprehensive perioperative care must integrate mental health screening to improve pain outcomes and mitigate opioid-related risks.
Background and Clinical Burden
Cesarean delivery remains the most common major surgical procedure performed globally. In the United States, approximately one in three births occurs via cesarean section. While surgical techniques and anesthesia protocols have evolved to optimize recovery, the management of postoperative pain remains a complex challenge, particularly within the context of the ongoing opioid epidemic. For many women, the postpartum period represents their first significant exposure to prescription opioids, creating a potential window for long-term dependency or misuse.
Simultaneously, maternal mental health disorders, specifically depression, are among the most frequent complications of pregnancy and the postpartum period. It is well-established in the general surgical literature that pre-existing psychological distress can exacerbate the experience of pain and complicate recovery. However, the specific interaction between maternal depression—differentiated by treatment status—and opioid consumption patterns following a cesarean birth has remained under-characterized. Understanding this relationship is vital for developing personalized pain management strategies that address both physical and psychological recovery.
Study Design and Methodology
To address this evidence gap, researchers conducted a secondary analysis of a large-scale, multicenter randomized trial involving 12 U.S. hospitals between 2020 and 2022. The study cohort included 5,504 participants who underwent cesarean delivery. The primary objective was to evaluate the association between a self-reported history of maternal depression and subsequent opioid use.
Exposure Classification
Participants were categorized based on their self-reported history of depression at the time of enrollment into three groups:
- No history of depression.
- Treated depression (defined as receiving pharmacologic or nonpharmacologic therapy during pregnancy).
- Untreated depression (history of depression but no active therapy during pregnancy).
Outcome Measures
The primary outcome was inpatient oral opioid use, measured in morphine milligram equivalents (MMEs) per day from 12 hours post-delivery until hospital discharge. Secondary outcomes included cumulative outpatient opioid use through six weeks postpartum and patient-reported outcomes via the Brief Pain Inventory (BPI) at one week post-discharge. The BPI assessed moderate-to-severe perceived pain (score ≥4) and the degree to which pain interfered with daily activities.
Statistical Analysis
The research team employed multivariable modeling to adjust for potential confounders. Quantile regression was utilized for continuous outcomes like MMEs, while logistic regression was used for binary outcomes such as pain interference. This robust statistical approach allowed for a nuanced comparison between treated and untreated depression relative to the control group (no depression).
Key Findings
The analysis revealed that 27.4% (n=1,507) of the study population had a self-reported history of depression. Within this group, only 44% were receiving treatment during pregnancy. Notable baseline differences emerged: individuals with depression (regardless of treatment) were more likely to have comorbid chronic pain conditions, use tobacco, and suffer from disordered sleep compared to those without depression.
Inpatient Opioid Consumption
Interestingly, the study found no significant association between depression status and inpatient opioid use. In the adjusted models, neither the treated nor the untreated depression groups showed a meaningful increase in MMEs per day while in the hospital. This finding suggests that standardized, protocol-driven inpatient pain management (such as scheduled non-opioid analgesics and nurse-administered PRN opioids) may effectively mask the influence of psychological factors on pain behavior in the immediate postoperative phase.
Outpatient Use and Pain Perception
The most striking results appeared in the outpatient phase. Patients with untreated depression used significantly more opioids after discharge. The adjusted median difference was 16.7 MMEs per day higher for the untreated group compared to those without depression (95% CI, 8.9–24.5). Furthermore, this group reported higher rates of moderate-to-severe pain at one week post-discharge.
When examining functional recovery, both treated and untreated depression groups experienced higher levels of pain interference in daily activities. The adjusted odds ratio (aOR) for pain interference was 1.44 (95% CI, 1.2–1.8) for the treated group and 1.37 (95% CI, 1.1–1.7) for the untreated group. This indicates that even when clinical depression is managed, the psychological vulnerability associated with a history of the disorder continues to impact how patients perceive and navigate pain in their home environment.
Expert Commentary and Clinical Implications
The divergence between inpatient and outpatient findings highlights a critical vulnerability in the current care continuum. In the hospital, patients are supported by clinical staff and structured dosing schedules. Once at home, the responsibility for pain management shifts to the patient, where psychological distress, sleep deprivation, and the demands of newborn care can amplify the sensation of pain and the perceived need for opioid relief.
Biological and Psychosocial Mechanisms
The association between untreated depression and increased opioid use may be driven by several mechanisms. Depression is often linked to central sensitization, where the nervous system remains in a state of high reactivity, lowering the pain threshold. Additionally, individuals with untreated depression may use opioids not only for nociceptive pain but also for “psychic pain” or as a maladaptive coping mechanism for anxiety and sleep disturbances. The fact that treated patients had lower opioid consumption than untreated patients—though still higher pain interference than the non-depressed cohort—suggests that mental health intervention provides a protective effect against escalating opioid use.
Study Limitations
While the study is large and multicenter, it relies on self-reported history rather than clinical diagnostic interviews, which may lead to some misclassification. Furthermore, the researchers did not specify the dosage or type of antidepressant medications, which could influence pain thresholds differently. However, the real-world nature of the data makes these findings highly generalizable to standard obstetric practice.
Conclusion
This study demonstrates that while hospital-based pain protocols may equalize opioid use in the short term, the influence of maternal mental health becomes evident once the patient returns home. Untreated depression is a significant risk factor for higher outpatient opioid consumption and poorer pain-related functional outcomes. For clinicians, these findings underscore the necessity of universal depression screening in the prenatal and early postpartum periods. Integrating mental health support into the surgical recovery plan is not just an adjunct to care; it is a fundamental requirement for responsible opioid stewardship and the optimization of maternal well-being.
Funding and References
This research was supported by the Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) Maternal-Fetal Medicine Units (MFMU) Network.
Reference: Pitt TL, Boekhoudt TM, Rood KM, et al. Maternal Depression and Opioid Use After Cesarean Delivery. Obstetrics and Gynecology. 2026; PMID: 41855534. Available at: https://pubmed.ncbi.nlm.nih.gov/41855534/